Reliance Industries will hold a meeting of the Board of Directors of the Company on 16 January 2025.Powered by Capital Market - Live

The Nifty January 2025 futures closed at 23,776.35, a premium of 87.4 points compared with the Nifty's closing 23,688.95 in the cash market. In the cash market, the Nifty 50 slipped 18.95 points or 0.08% to 23,688.95. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, declined 1.33% to 14.47. Reliance Industries, Tata Motors, and Dixon Technologies (India) were the top trading individual stock futures contracts in the F&O segment of the NSE. The January 2025 F&O contracts will expire on 30 January 2025.Powered by Capital Market - Live

The Nifty January 2025 futures closed at 23,730, a premium of 113.95 points compared with the Nifty's closing 23,616.05 in the cash market. In the cash market, the Nifty 50 slipped 388.70 points or 1.62% to 23,616.05. The NSE's India VIX, a gauge of market's expectation of volatility over the near term, jumped 15.58% to 15.65. Reliance, Tata Motors, and HDFC Bank were the top-trading individual stock futures contracts in the F&O segment of the NSE. The January 2025 F&O contracts will expire on 30 January 2025.Powered by Capital Market - Live

The Nifty January 2024 futures closed at 24,270.10, a premium of 81.45 points compared with the Nifty's closing 24,188.65 in the cash market. In the cash market, the Nifty 50 soared 445.75 points or 1.88% to 24,188.65. The NSE's India VIX, a gauge of market's expectation of volatility over the near term, dropped 5.30% to 13.74. Reliance Industries, Maruti Suzuki India and Tata Motors and were the top traded individual stock futures contracts in F&O segment of NSE. The January 2025 F&O contracts will expire on 30 January 2025. Powered by Capital Market - Live

The Nifty January 2024 futures closed at 23,907, a premium of 164.10 points compared with the Nifty's closing 23,742.90 in the cash market. In the cash market, the Nifty 50 added 98.10 points or 0.41% to 23,742.90. The NSE's India VIX, a gauge of market's expectation of volatility over the near term, rose 0.41% to 14.51 Reliance Industries, Maruti Suzuki India and HDFC Bank and were the top traded individual stock futures contracts in F&O segment of NSE. The January 2025 F&O contracts will expire on 30 January 2025. Powered by Capital Market - Live

The acquisition was made by subscribing to 1 crore equity shares worth Rs 10 crore and allotting 36.50 crore optionally fully convertible debentures (OFCDs) for Rs 365 crore in Karkinos. As part of the acquisition, Karkinos has cancelled 30,075 outstanding equity shares held by the previous shareholders in accordance with the approved resolution plan. With the completion of the equity share allotment to RSBVL and the cancellation of existing shares, Karkinos is now a step-down wholly-owned subsidiary of Reliance Industries. Karkinos was incorporated in India on 24 July 2020, and is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer. The company reported a turnover of Rs 21.91 crore for FY 2023, compared to Rs 0.92 crore in FY 2022 and Rs 0.004 crore in FY 2021. The acquisition of Karkinos will help expand the health services business portfolio of the Reliance group. The resolution plan for Karkinos was approved by the Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench, and no additional governmental or regulatory approvals were needed for the transaction. The company clarified that the investment does not fall under a related party transaction, and neither the company's promoters nor its group companies have any interest in the deal. Earlier, on 10, December 2024, Reliance announced that the NCLT had approved the resolution plan submitted by RSBVL for Karkinos under the Corporate Insolvency Resolution Process of the Insolvency and Bankruptcy Code, 2016. Reliance Industries (RIL) is India's largest private sector company. Its activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, renewables (solar and hydrogen), retail and digital services. RIL had reported a 3.6% fall in consolidated net profit to Rs 19,101 crore in Q2 FY25 from Rs 19,820 crore in Q2 FY24. Gross revenue rose by 0.8% YoY to Rs 258,027 crore in the second quarter. The scrip had rose 0.36% to end at Rs 1,220.95 on the BSE on Friday. Powered by Capital Market - Live

Reliance Industries announced that in accordance with the approved resolution plan for the resolution of Karkinos Healthcare (Karkinos), Reliance Strategic Business Ventures (RSBVL), wholly-owned subsidiary of the Company, has on 27 December 2024, subscribed to and has been allotted 1,00,00,000 equity shares of Rs. 10/- each, for cash, aggregating Rs. 10 crore and 36,50,00,000 Optionally Fully Convertible Debentures of Rs. 10/- each, for cash, aggregating Rs. 365 crore of Karkinos. Further, Karkinos has cancelled the existing outstanding 30,075 equity shares held by the erstwhile shareholders of Karkinos in accordance with the approved resolution plan. Post allotment of equity shares to RSBVL and cancellation of existing outstanding equity shares as above, Karkinos has become a step down wholly-owned subsidiary of the Company. Karkinos was incorporated in India on July 24, 2020 and is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer.Powered by Capital Market - Live

NSE India VIX jumped 6.50% to 14.04. The Nifty December 2024 futures closed at 23,748.75, a discount of 1.45 points compared with the Nifty's closing 23,750.20 in the cash market. In the cash market, the Nifty 50 rose 25.55 points or 0.10% to 23,750.20. The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, jumped 6.50% to 14.04. Reliance Industries, Tata Motors and State Bank of India were the top traded individual stock futures contracts in the F&O segment of NSE. The November 2024 F&O contracts will expire on 26 December 2024. Powered by Capital Market - Live

HAGI is a US-based healthcare company incorporated on 21 December 2023, as a Delaware corporation. It specializes in designing technology-driven solutions for the underserved in the United States, India and rest of the world. It operates at the intersection of healthcare, information technology, and innovation. The investment will empower RDHL to develop a virtual diagnostic and care platform, expanding access to healthcare for underserved communities. The transaction is subject to customary closing conditions and is expected to be completed in around 2 weeks. Reliance Industries (RIL) is India's largest private sector company. Its activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, renewables (solar and hydrogen), retail and digital services. RIL had reported a 3.6% fall in consolidated net profit to Rs 19,101 crore in Q2 FY25 from Rs 19,820 crore in Q2 FY24. Gross revenue rose by 0.8% YoY to Rs 258,027 crore in the second quarter. The scrip slipped 2% to close at Rs 1,206 on Friday, 20 December 2024. Powered by Capital Market - Live

Reliance Digital Health (RDHL), a wholly owned subsidiary of Reliance Industries, has on 20 December 2024 entered into definitive agreements to acquire 45% equity stake on a fully diluted basis in Health Alliance Group Inc. (HAGI) for an aggregate consideration of USD 10 million. Powered by Capital Market - Live